Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma?
The results of the current study indicate that gallbladder carcinoma patients who undergo noncurative resections may derive some benefit from systemic chemotherapy. However, alternative modalities must be developed for patients with carcinomas of the pancreas, bile duct, or ampulla of Vater.
miR-1247-5p is overexpressed in CRPC and targets MYCBP2.